Divi's Laboratories Ltd. shareholder votes
The exchange lists 6 meetings for Divi's Laboratories Ltd. with 20 resolutions put to shareholders; 0 failed and 2 passed with 10 percent or more against. The latest, a agm on 10 August 2026, put 4 resolutions to the vote, the lowest support 99.69% for.
| Meeting | Resolution | Kind | For | Against | Filing |
|---|---|---|---|---|---|
| AGM, 10 August 2026 | To consider and adopt the audited financial statements of the Company, both standalone and consolidated, for the financial year ended March 31, 2026, and the reports of the Board of Directors��� and Auditors��� thereon. | Ordinary | 99.95% | 0.05% | NSE |
| AGM, 10 August 2026 | To appoint a director in place of Dr. Kiran S. Divi (DIN: 00006503), who retires by rotation at this Annual General Meeting and being eligible, offers himself for re-appointment. | Ordinary | 99.80% | 0.20% | NSE |
| AGM, 10 August 2026 | To appoint a director in place of Mr. N.V. Ramana (DIN: 00005031), who retires by rotation at this Annual General Meeting and being eligible, offers himself for re-appointment. | Ordinary | 99.69% | 0.31% | NSE |
| AGM, 10 August 2026 | To declare dividend of Rs.30/- per equity share of face value Rs.2/- each (i.e.@ 1,500%) for the financial year ended March 31, 2026. | Ordinary | 100.00% | 0.00% | NSE |
| AGM, 11 August 2025 | To consider and adopt the audited financial statements of the Company, both standalone and consolidated, for the financial year ended March 31, 2025, and the reports of the Board of Directors��� and Auditors��� thereon. | Ordinary | 99.98% | 0.02% | NSE |
| AGM, 11 August 2025 | To approve enhancement of remuneration of Mr. Nimmagadda Venkata Anirudh, Head of Nutraceuticals, a related party. | Ordinary | 87.63% | 12.37% | NSE |
| AGM, 11 August 2025 | To appoint M/s. V. Bhaskara Rao & Co., Practicing Company Secretaries, as Secretarial Auditors of the Company. | Ordinary | 99.98% | 0.02% | NSE |
| AGM, 11 August 2025 | To appoint a director in place of Dr. S. Devendra Rao (DIN: 10481393), who retires by rotation at this Annual General Meeting and being eligible, offers himself for re-appointment. | Ordinary | 99.60% | 0.40% | NSE |
| AGM, 11 August 2025 | To appoint a director in place of Ms. Nilima Prasad Divi (DIN: 06388001), who retires by rotation at this Annual General Meeting and being eligible, offers herself for re-appointment. | Ordinary | 99.59% | 0.41% | NSE |
| AGM, 11 August 2025 | To declare dividend of Rs.30/- per equity share of face value Rs.2/- each (i.e. 1,500%) for the financial year ended March 31, 2025 | Ordinary | 100.00% | 0.00% | NSE |
| AGM, 11 August 2025 | To approve enhancement of remuneration of Mr. Nimmagadda Venkata Anirudh, Head of Nutraceuticals, a related party. | Ordinary | 87.63% | 12.37% | NSE |
| AGM, 11 August 2025 | To appoint M/s. V. Bhaskara Rao & Co., Practicing Company Secretaries, as Secretarial Auditors of the Company. | Ordinary | 99.98% | 0.02% | NSE |
| AGM, 11 August 2025 | To appoint a director in place of Dr. S. Devendra Rao (DIN: 10481393), who retires by rotation at this Annual General Meeting and being eligible, offers himself for re-appointment. | Ordinary | 99.60% | 0.40% | NSE |
| AGM, 11 August 2025 | To appoint a director in place of Ms. Nilima Prasad Divi (DIN: 06388001), who retires by rotation at this Annual General Meeting and being eligible, offers herself for re-appointment. | Ordinary | 99.59% | 0.41% | NSE |
| AGM, 11 August 2025 | To declare dividend of Rs.30/- per equity share of face value Rs.2/- each (i.e. 1,500%) for the financial year ended March 31, 2025 | Ordinary | 100.00% | 0.00% | NSE |
| AGM, 11 August 2025 | To consider and adopt the audited financial statements of the Company, both standalone and consolidated, for the financial year ended March 31, 2025, and the reports of the Board of Directors��� and Auditors��� thereon. | Ordinary | 99.98% | 0.02% | NSE |
| Postal Ballot, 6 March 2025 | Re-appointment of Dr. Kiran S. Divi (DIN: 00006503) as Whole-time Director and Chief Executive Officer of the Company | Special | 95.87% | 4.13% | NSE |
| Postal Ballot, 6 March 2025 | Re-appointment of Dr. Kiran S. Divi (DIN: 00006503) as Whole-time Director and Chief Executive Officer of the Company | Special | 95.87% | 4.13% | NSE |
| AGM, 12 August 2024 | To consider and adopt the audited financial statements of the Company, both standalone and consolidated, for the financial year ended March 31, 2024, and the reports of the Board of Directors��� and Auditors��� thereon | Ordinary | 100.00% | 0.00% | NSE |
| AGM, 12 August 2024 | To declare dividend of Rs. 30/- per Equity Share of face value Rs. 2/-each (i.e. @ 1500%) for the financial year ended March 31, 2024 | Ordinary | 99.78% | 0.22% | NSE |
An ordinary resolution passes with more than half the votes cast, a special resolution with more than three quarters. Percentages are the totals the company reported to the exchange across all shareholder classes. The exchange's list carries recent meetings, not the whole history.
Source
Voting results on nseindia.com for DIVISLAB.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.